cetuximab,encorafenib
pfizer,merck,eli lilly
['breakwater']
mini-orals lower gi! #esmo22 discussing safety lead-in of breakwater study 
Medical Oncologist, GI cancers @nki_nl neoadjuvant #immunotherapy #cancerresearch. Opinions my own